AbCellera Biologics Inc. ABCL Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s net change in cash?
- AbCellera Biologics Inc. (ABCL) reported net change in cash of -$51.45M in Q1 2026.
- How has AbCellera Biologics Inc.'s net change in cash changed year-over-year?
- AbCellera Biologics Inc.'s net change in cash decreased by 1849.4% year-over-year, from $2.94M to -$51.45M.
- What is the long-term trend for AbCellera Biologics Inc.'s net change in cash?
- Over 2 years (2021 to 2024), AbCellera Biologics Inc.'s net change in cash has grown at a -50.3% compound annual growth rate (CAGR), from -$92.97M to $23.01M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.